PURE Bioscience, Inc.
PURE
$0.0675
$0.006711.02%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 22.15% | 14.95% | 10.78% | 15.43% | 12.88% |
| Total Depreciation and Amortization | -68.00% | -39.52% | -10.48% | 26.50% | -18.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -73.91% | -64.69% | -62.48% | -59.29% | -27.38% |
| Change in Net Operating Assets | 111.56% | 203.83% | 270.21% | 471.03% | 316.67% |
| Cash from Operations | 19.76% | 17.46% | 7.88% | 22.79% | 14.50% |
| Capital Expenditure | -- | -- | -- | -- | 146.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 146.24% |
| Total Debt Issued | -2.17% | 5.56% | -16.67% | 75.86% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.17% | 5.56% | -16.67% | 75.86% | -34.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128.91% | 61.75% | -8.10% | 67.51% | -225.56% |